Clin Nutr:维生素D缺陷可增加鼻咽癌风险?

2021-09-02 Nebula MedSci原创

在体重指数正常的受试者中维生素D水平与鼻咽癌风险呈负相关

鼻咽癌(NPC)在人种和地域分布上有明显的分布差异,尤其是在东亚和东南亚。维生素 D 暴露水平与鼻咽癌风险是否存在相关性尚不明确。本研究旨在评估鼻咽癌风险与血清 25-羟维生素D 水平以及遗传预测的 25-羟维生素D 之间的相关性。

Low vitamin D exposure and risk of nasopharyngeal carcinoma: Observational and genetic evidence from a multicenter case-control study

这是一项在香港开展的多中心病例对照研究,从五家主要的地区医院招募了815位鼻咽癌患者和1502位性别和年龄相匹配的医院对照,并另外从血站招募了299位健康对照(2014年-2017年)。通过酶免疫分析检测了 25-羟维生素D 的循环水平,通过 MassARRAY 系统的 iPLEX 实验验证了遗传预测的 25-羟维生素D (rs12785878、rs11234027、rs12794714、rs4588和rs6013897)。还使用计算机辅助、自我管理问卷收集了有关人口统计学、生活方式因素、紫外线辐射暴露和潜在混杂因素的数据。

25-羟维生素D水平与鼻咽癌风险的相关性

虽然鼻咽癌风险与循环 25-羟维生素D 和遗传预测的 25-羟维生素D 水平无显著相关性,但有证据表明,在体重指数正常(BMI:18.5-27.5)的受试者中两者呈负相关性(p=0.003),而在社会经济地位较低的受试者中呈正相关性(p=0.005)。此外,在遗传性低 25-羟维生素D 水平的受试者中,早期确诊鼻咽癌的风险相对更高(校正优势比[OR] 3.09, 95% CI 1.04-9.21,p=0.022)。

这是首个研究鼻咽癌风险与维生素D 缺陷相关性的综合性研究,研究结果需进一步验证。

原始出处:

Mai Zhi-Ming,Ngan Roger Kai-Cheong,Ng Wai-Tong et al. Low vitamin D exposure and risk of nasopharyngeal carcinoma: Observational and genetic evidence from a multicenter case-control study.[J] .Clin Nutr, 2021, 40: 5180-5188. https://doi.org/10.1016/j.clnu.2021.07.034

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2062036, encodeId=ca6b20620362e, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jul 04 13:08:56 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079583, encodeId=588b10e958382, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710b4868428, createdName=爱吃芒果vv, createdTime=Mon Dec 13 15:41:00 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013804, encodeId=f8e410138046f, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22af5591948, createdName=ms8000002022599781, createdTime=Thu Sep 02 16:37:47 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013792, encodeId=c1ad1013e9235, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68522530515, createdName=124fe80fm82暂无昵称, createdTime=Thu Sep 02 15:59:00 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013787, encodeId=08a11013e87bb, content=🌸🌸🌸, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5425563316, createdName=ms2000001730191797, createdTime=Thu Sep 02 15:52:32 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2022-07-04 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2062036, encodeId=ca6b20620362e, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jul 04 13:08:56 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079583, encodeId=588b10e958382, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710b4868428, createdName=爱吃芒果vv, createdTime=Mon Dec 13 15:41:00 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013804, encodeId=f8e410138046f, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22af5591948, createdName=ms8000002022599781, createdTime=Thu Sep 02 16:37:47 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013792, encodeId=c1ad1013e9235, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68522530515, createdName=124fe80fm82暂无昵称, createdTime=Thu Sep 02 15:59:00 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013787, encodeId=08a11013e87bb, content=🌸🌸🌸, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5425563316, createdName=ms2000001730191797, createdTime=Thu Sep 02 15:52:32 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2021-12-13 爱吃芒果vv

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2062036, encodeId=ca6b20620362e, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jul 04 13:08:56 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079583, encodeId=588b10e958382, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710b4868428, createdName=爱吃芒果vv, createdTime=Mon Dec 13 15:41:00 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013804, encodeId=f8e410138046f, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22af5591948, createdName=ms8000002022599781, createdTime=Thu Sep 02 16:37:47 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013792, encodeId=c1ad1013e9235, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68522530515, createdName=124fe80fm82暂无昵称, createdTime=Thu Sep 02 15:59:00 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013787, encodeId=08a11013e87bb, content=🌸🌸🌸, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5425563316, createdName=ms2000001730191797, createdTime=Thu Sep 02 15:52:32 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2021-09-02 ms8000002022599781

    学习了,涨知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2062036, encodeId=ca6b20620362e, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jul 04 13:08:56 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079583, encodeId=588b10e958382, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710b4868428, createdName=爱吃芒果vv, createdTime=Mon Dec 13 15:41:00 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013804, encodeId=f8e410138046f, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22af5591948, createdName=ms8000002022599781, createdTime=Thu Sep 02 16:37:47 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013792, encodeId=c1ad1013e9235, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68522530515, createdName=124fe80fm82暂无昵称, createdTime=Thu Sep 02 15:59:00 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013787, encodeId=08a11013e87bb, content=🌸🌸🌸, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5425563316, createdName=ms2000001730191797, createdTime=Thu Sep 02 15:52:32 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2021-09-02 124fe80fm82暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2062036, encodeId=ca6b20620362e, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Jul 04 13:08:56 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079583, encodeId=588b10e958382, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710b4868428, createdName=爱吃芒果vv, createdTime=Mon Dec 13 15:41:00 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013804, encodeId=f8e410138046f, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22af5591948, createdName=ms8000002022599781, createdTime=Thu Sep 02 16:37:47 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013792, encodeId=c1ad1013e9235, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68522530515, createdName=124fe80fm82暂无昵称, createdTime=Thu Sep 02 15:59:00 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013787, encodeId=08a11013e87bb, content=🌸🌸🌸, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5425563316, createdName=ms2000001730191797, createdTime=Thu Sep 02 15:52:32 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2021-09-02 ms2000001730191797

    🌸🌸🌸

    0

相关资讯

J Allergy Clin Immunol Pract:产前维生素D与儿童早期气源性过敏原致敏和过敏性鼻炎的关系

维生素D具有免疫调节作用,可能对过敏性疾病的发展具有重要作用,也许早在胎儿发育的前三个月就开始起作用了。研究表明,母体的维生素D可以自由穿过胎盘,其水平可以通过母体的饮食和补充来改变。维生素D的缺乏已

Clin Gastroenterology H: 大剂量维生素 D 的使用不能预防克罗恩病术后复发

维生素 D 在肠道中具有抗炎和抗纤维化的特性。但是有研究显示,大多数患有克罗恩病 (CD) 和其他免疫介导疾病的患者中血清 25-羟基维生素 D(25-OH 维生素 D)浓度均较低。

Gastroenterology:大规模研究表明,维生素D可预防结直肠癌,且食物中的效果更好

虽然结直肠癌的总体发病率一直在下降,但年轻人的病例却在增加。预计到2030年,近11%的结肠癌和23%的直肠癌发生在50岁以下的美国成年人中。因为相当大比例的早发结直肠癌患者没有结直肠癌家族史或已知的

维生素D具有抗癌效果,且在老年时期更明显!

近日发表在BMC Public Health上的一项研究发现,紫外线(UVB)暴露与结肠癌粗发病率之间具有反比关系,且这种关系在老年群体中更为强烈。

JCC: 维生素D与炎症性肠病患者体内α4β7+免疫表型相关并可以预测维多珠单抗治疗失败概率

整合素α4β7是促进白细胞运输到肠道,导致肠道炎症产生的重要粘附分子。

Gastroenterology:维生素D总摄入量和早发性结直肠癌的风险相关

很多观察性研究发现,血液中维生素D含量越高,患结肠癌的风险越低。